Winter Meeting Swiss Society of Cardiology, Feusisberg
DRGs have been introduced in Switzerland with great controversy. While diagnosis related groups increase efficiency and quality in the hospital setting, critics fear the end of innovation. This presentation shows how innovation isn’t linked to the tariff system and how it can be ensured in a future including DRGs. Innovation will not solely be on the industry’s and academia’s agenda. Payors play a key role in guaranteeing innovation.